UCB is a global biopharmaceutical company with a shared ambition to transform the lives of people living with severe diseases. With a focus on central nervous system and immunology disorders, UCB puts patients at the center of their world.
Reducing the risk of SUDEP: What GPs need to know
Part 1 of this 2-hour module contains information about SUDEP (sudden unexpected death in epilepsy) and strategies for discussing the risks of SUDEP with patients and their families. In part 2 you will be asked to use the SUDEP and Seizure Safety Checklist, to assess two people with epilepsy in your practice.
Managing epilepsy in older people: Optimising outcomes in general practice
Epilepsy is a common problem for older adults, and has a greater impact in older people compared to younger populations. This module describes key differences between the causes and presentation of epilepsy in older versus younger people, as well as special considerations for prescribing antiseizure drugs for older people. This two-hour activity contains a online learning module as well as a patient review exercise involving preparation of a GP Management Plan for a patient.
